Influence
May 14, 2020

In New York Times opinion piece, Regenstrief VP presents COVID-19 data recommendations for states

As states are beginning to reopen in the face of COVID-19, many are doing so without enough data, according to Regenstrief Institute Vice President for Faculty and Development Aaron Carroll, M.D. In a recent opinion column for the New York Times, Dr. Carroll made an exception: Indiana.

He discussed the groundbreaking COVID-19 testing study being led by Regenstrief research scientist and IU Fairbanks School of Public Health faculty member Nir Menachemi, PhD, MPH.

The study, which tested 4,600 people in its first phase, has found that 2.8 percent of Hoosiers are either infected with the coronavirus or have recovered. While these findings suggested a mortality rate of about 0.6 percent, lower than some experts have suggested, the study also indicated that 10 out of 11 cases of COVID-19 in the state’s population are not being caught due to low testing rates.

“We need much more data,” Dr. Carroll writes, “too many states are flying blind, moving ahead without understanding their risk. There’s no excuse for that. There’s no magic to what’s just been done in Indiana. All states could do it if they just committed to it.”

Since early in the pandemic, Dr. Carroll has warned about the potential of the virus to overwhelm the healthcare system and has been an advocate for nationwide social distancing and mass testing of the population as a means to contain the virus.

READ THE ARTICLE

Related News

Susan Hickman and Kathleen Unroe lead expansion of advance care planning program

Leadership stability, peer support essential when implementing care programs in nursing homes

Despite a pressing need to improve outcomes and address inequities in nursing homes, there is limited evidence about the

Reimagining real-world health data as essential public infrastructure

Reimagining real-world health data as essential public infrastructure

Researchers propose standards and community oversight to improve interoperability, accountability and public trust The U.S. healthcare system runs on

Arthur H. Owora, PhD

Real-world effectiveness of asthma biologics by age of initiation and early-childhood risk factors

Published in Annals of the American Thoracic Society. Here is a link to the article.  Regenstrief Institute author: Arthur H. Owora, PhD,

LOINC® advances global health interoperability with semiannual concept release

LOINC® version 2.82 introduces new terminology and technical enhancements to support global data exchange Regenstrief Institute launched the LOINC®